tiprankstipranks
Trending News
More News >
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Income Statement

Compare
413 Followers

ADC Therapeutics Income Statement

Last quarter (Q4 2025), ADC Therapeutics's total revenue was $23.06M, an increase of 36.36% from the same quarter last year. In Q4, ADC Therapeutics's net income was $-6.41M. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 81.36M$ 70.84M$ 69.56M$ 209.91M$ 33.92M
Gross Profit
$ 73.68M$ 64.89M$ 67.03M$ 206.61M$ 32.52M
Operating Expenses
$ 182.06M$ 195.54M$ 233.01M$ 329.95M$ 294.24M
Depreciation and Amortization
$ 1.88M$ 3.28M$ 3.27M$ 2.39M$ 2.63M
EBITDA
$ -106.50M$ -102.65M$ -145.83M$ -107.70M$ -230.53M
Operating Income
$ -108.38M$ -130.65M$ -165.99M$ -123.34M$ -261.72M
Other Income/Expenses
$ -34.40M$ -27.03M$ -34.96M$ -33.56M$ 10.21M
Pretax Income
$ -142.78M$ -157.68M$ -200.95M$ -156.90M$ -251.50M
Net Income
$ -142.62M$ -157.85M$ -240.05M$ -157.13M$ -230.03M
Per Share Metrics
Basic EPS
$ -1.12$ -1.62$ -2.94$ -1.99$ -3.00
Diluted EPS
$ -1.12$ -1.62$ -2.94$ -1.99$ -3.00
Weighted Average Shares Outstanding
127.07M 97.16M 81.71M 78.15M 76.75M
Weighted Average Shares Outstanding (Diluted)
127.07M 97.16M 81.71M 78.15M 76.75M
Currency in USD

ADC Therapeutics Earnings and Revenue History